Skip to main content
. 2022 May 27;27(11):3460. doi: 10.3390/molecules27113460

Figure 1.

Figure 1

The drug incorporation models of SLNs (A) homogeneous matrix, (B) drug-enriched shell, (C) drug-enriched core.